RDH16 Inhibitors

Chemical inhibitors of RDH16 target various aspects of the protein's function and structure to achieve inhibition. Retinoic acid, a metabolite of the vitamin A pathway, competes with retinol for binding to RDH16, effectively blocking the substrate from the active site and inhibiting the enzyme's catalytic activity. Similarly, isotretinoin, a retinoic acid analog, occupies the active site of RDH16 due to its structural similarity with retinoids, preventing the binding and processing of the natural substrate, retinol. Citral, another compound with an aldehyde group, can mimic the natural substrate retinal and bind to RDH16's active site, thereby obstructing its normal function.

N,N-Dimethylformamide and Triethylamine can perturb the enzyme's activity by altering its structural conformation. N,N-Dimethylformamide induces changes in RDH16's tertiary structure through solvent effects, potentially leading to a nonfunctional enzyme configuration. Triethylamine affects RDH16 by altering the pH, which can cause denaturation or unfavorable structural changes, impeding the enzyme's function. Methimazole and disulfiram exert their inhibitory effects through interactions with RDH16's cofactors and active site residues. Methimazole binds to the zinc cofactor, which is vital for the enzyme's activity, while disulfiram modifies cysteine residues at the active site, disrupting the enzyme's catalytic capabilities. Iodoacetamide and α-Lipoic acid inhibit RDH16 through covalent modifications. Iodoacetamide alkylates thiol groups of cysteine residues within RDH16, critical for the enzyme's function, thus leading to inhibition. α-Lipoic acid can react with disulfide bonds within RDH16, causing a conformational change that inhibits enzyme activity. Lead(II) acetate and zinc pyrithione inhibit RDH16 by targeting essential thiol groups or displacing the zinc cofactor necessary for enzyme activity. Lead(II) acetate can bind to thiol groups or replace zinc, disturbing the catalytic function, while zinc pyrithione binds to the same sites as the zinc cofactor, interfering with the RDH16's proper enzymatic activity. Each of these chemicals, through distinct biochemical interactions, can inhibit the function of RDH16 by preventing the binding of its substrates or disrupting its catalytic mechanism.